ANI Pharmaceuticals(ANIP) - 2024 Q3 - Quarterly Results

Exhibit 99.1 FOR IMMEDIATE RELEASE ANI Pharmaceuticals Reports Record Third Quarter 2024 Financial Results and Raises 2024 Guidance • Generated record quarterly net revenues of $148.3 million, representing year-over-year growth of 12.5%, and record Purified Cortrophin® Gel net revenues of $52.6 million, an increase of 76.8% year-over-year • Net loss of $(24.2) million and adjusted non-GAAP EBITDA of $35.1 million • Diluted GAAP loss per share of $(1.27) and adjusted non-GAAP diluted earnings per share of $1 ...